ODYSSEY HEALTH INC (ODYY) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Jun 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ODYY SEC filings page.
This page shows ODYSSEY HEALTH INC (ODYY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Odyssey has no reported revenue, while shrinking assets and rising liabilities leave the business financed primarily by obligations rather than operations.
From FY2023 to FY2025, the company’s reported assets contracted from$456K to$50K . Over the same span, liabilities increased from$6.6M to$7.0M , leaving obligations increasingly unsupported by reported assets.
FY2024’s net loss of
By FY2025, current assets were just
Financial Health Signals
ODYSSEY HEALTH INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
ODYSSEY HEALTH INC reported $766K in net income in Q3 2026. This represents an increase of 404.2% from the same quarter a year earlier. Against the prior quarter it is up 121.3%.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
ODYSSEY HEALTH INC held $298K in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
ODYY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $0-100.0% | N/A |
| SG&A Expenses | $298K+130.6% | $182K+16.2% | $303K-47.7% | N/A | $129K-59.8% | $157K-64.2% | $579K+15.6% | N/A |
| Operating Income | -$298K-130.6% | -$182K-16.2% | -$303K+47.7% | N/A | -$129K+65.3% | -$157K+86.5% | -$579K-66.9% | N/A |
| EBITDA | N/A | N/A | N/A | N/A | -$129K+65.3% | -$157K+86.5% | -$579K-67.3% | N/A |
| Interest Expense | $528K+759.3% | $412K+550.2% | $95K+38.6% | N/A | $61K-39.9% | $63K-55.2% | $69K-64.0% | N/A |
| Net Income | $766K+404.2% | -$3.6M-1536.2% | -$483K+52.6% | N/A | -$252K+70.1% | -$220K-101.7% | -$1.0M-89.4% | N/A |
| EPS (Basic) | $0.01 | -$0.03 | $0.00+100.0% | -$0.01+92.9% | $0.00+100.0% | $0.00-100.0% | -$0.010.0% | -$0.14-1300.0% |
| EPS (Diluted) | $0.01 | -$0.03 | $0.00+100.0% | -$0.01+91.7% | $0.00+100.0% | $0.00-100.0% | -$0.01 | -$0.12-1100.0% |
| Diluted Shares (Avg) | 187M+78.3% | 108M+3.0% | 106M+1.3% | N/A | 105M+0.9% | 105M-8.2% | 105M | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.
ODYY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $374K+127.2% | $721K+170.3% | $144K-57.9% | $50K-91.5% | $165K-98.8% | $267K-98.1% | $341K-44.3% | $586K+28.6% |
| Current Assets | $374K+454.9% | $721K+565.6% | $144K-21.3% | $50K-12.7% | $67K-56.1% | $108K-58.2% | $183K-67.6% | $57K-86.0% |
| Cash & Equivalents | $298K+9247.3% | $616K+8475.6% | $26K-52.5% | $19K+702.2% | $3K-95.2% | $7K-95.7% | $54K-72.8% | $2K-93.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $10.1M+254.8% | $11.3M+68.2% | $7.3M+10.3% | $7.0M+18.3% | -$6.5M-214.8% | $6.7M+25.1% | $6.6M-3.1% | $5.9M-10.5% |
| Current Liabilities | $10.1M+47.4% | $11.3M+68.2% | $7.3M+10.3% | $7.0M+18.3% | $6.9M+20.6% | $6.7M+25.1% | $6.6M-3.1% | $5.9M-10.5% |
| Non-Current Liabilities | $0+100.0% | $0 | $0 | $0 | -$13.4M | $0 | $0 | $0 |
| Total Equity | -$9.7M-245.5% | -$10.6M-64.0% | -$7.2M-14.0% | -$7.0M-30.4% | $6.7M-14.9% | -$6.5M-174.5% | -$6.3M-1.0% | -$5.3M+13.4% |
| Retained Earnings | -$66.1M-5.7% | -$66.8M-7.4% | -$63.2M-1.9% | -$62.7M-2.9% | -$62.5M-29.5% | -$62.2M-31.3% | -$62.0M-2.3% | -$61.0M-1.5% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ODYY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$319K-7861.0% | -$284K-509.0% | -$284K-14.3% | -$48K+24.3% | -$4K+97.8% | -$47K+94.9% | -$249K-314.8% | -$64K+46.9% |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $0-100.0% | $0-100.0% |
| Stock-Based Compensation | N/A | N/A | $0-100.0% | N/A | N/A | N/A | $60K-81.3% | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $70K | $0 | N/A | N/A | $0+100.0% |
| Financing Cash Flow | $0 | $875K | $291K-3.2% | -$6K | $0-100.0% | $0+100.0% | $300K+35.8% | $0-100.0% |
| Dividends Paid | N/A | N/A | N/A | N/A | $0 | $0-100.0% | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
ODYY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | N/A | N/A | N/A | N/A | -3.8%+6.9pp | N/A | N/A | N/A |
| Return on Assets | 204.9%+357.9pp | -499.3%-416.8pp | -336.6%-37.8pp | N/A | -153.0%-146.8pp | -82.5%-177.0pp | -298.8%-210.9pp | N/A |
| Current Ratio | 0.040.0x | 0.060.0x | 0.020.0x | 0.010.0x | 0.010.0x | 0.020.0x | 0.03-0.1x | 0.01-0.1x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$7.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ODYSSEY HEALTH INC ODYY | FY2025 | N/A | N/A | N/A | $818K | — |
| STIMCELL ENERGETICS INC STME | FY2026 | N/A | N/A | N/A | $4.9M | — |
| ADM TRONICS UNLTD INC ADMT | FY2026 | $3.3M | -$100K | -3.0% | $2.7M | — |
Where ODYSSEY HEALTH INC Ranks
Frequently Asked Questions
What are ODYSSEY HEALTH INC's total assets?
ODYSSEY HEALTH INC (ODYY) had $50K in total assets as of fiscal year 2025, including both current and long-term assets.
What is ODYSSEY HEALTH INC's current ratio?
ODYSSEY HEALTH INC (ODYY) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is ODYSSEY HEALTH INC's P/E ratio?
ODYSSEY HEALTH INC (ODYY) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $818K as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ODYSSEY HEALTH INC's price-to-sales ratio?
ODYSSEY HEALTH INC (ODYY) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $818K as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is ODYSSEY HEALTH INC's debt-to-equity ratio negative or not reported?
ODYSSEY HEALTH INC (ODYY) has negative shareholder equity of -$7.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.